News Contact Location Quality Technology Custom Manufacturing Products

In retrospect of the latest CPhI worldwide

On 5th of November 2019 at 9.30 am it was that time again – the CPhI Worldwide (Convention on Pharmaceutical Ingredients) opened its doors, this year in Frankfurt (Germany). Just as before, the team of Arevipharma was present with a share of the Midas Pharma booth. With approx. 45.000 visitors as well as approx. 2.500 exhibitors the CPhI is always an excellent platform for deepening of existing as well as initiating of new business relationships. The positive trend of Arevipharma, with the major topics exclusive contract manufacturing (CMO) as well as improving our competitiveness due to structural and strategic investments, was taken on a good note by the clients base.

By now, all colleagues safely returned to Arevipharmas site in Radebeul (Germany). But that is just the kick off for the actual work to be done, because there are a lot of meeting minutes to be followed-up.

Arevipharma begrüßt Sie auf der CPhI in Frankfurt 2019

Arevipharma ist wie jedes Jahr auf der CPhI Worldwide mit einem starken Vertriebsteam vertreten.

Wir begrüßen Sie vom 05.11.2019 bis 07.11.2019 in Frankfurt am Stand 40C11

Neben dem bestehenden Produktportfolio stellen wir Ihnen gern unsere technischen Möglichkeiten im Bereich individueller Auftragssynthesen und unsere neuen Anlagen vor.
Wir freuen uns auf spannende, erfolgreiche Gespräche und Projekte.

Arevipharma – quality made in Germany.

Certificate of suitability received!
R0-CEP 2018-070-Rev 00

In April 2019, Arevipharma have received its Certificate of Suitability for Remifentanil Hydrochloride thus being one of the first global suppliers of this API with a CEP. A fact Arevipharma are justifiably proud of.

Arevipharma are one of the largest German manufacturers of narcotic generics. The production of narcotics at the site Radebeul located close to Dresden has a long tradition. Today, Arevipharma, being appreciated for its excellent know-how and premium quality, supply its products all over the world.

Do we have awakened your interest in Remifentanil Hydrochloride or any other narcotic substance of our portfolio?

Please do not hesitate to contact us. We will be happy to answer your questions and help you with sample quotations.

 
 

Sales

Claudia Böttcher

Tel.: +49 (0)351 8314-1238

Sales

Kerstin Dreissig

Tel.: +49 (0)351 8314-1120


Arevipharma GmbH
Meißner Straße 35
D-01445 Radebeul
Web: www.arevipharma.com
Telefon: +49 (0)351 8314-0
Telefax: +49 (0)351 8314-2100
Geschäftsführung
Herr Dr. Hendrik Baumann
Herr Daniel Hoffmann
Herr Dr. Dirk Jung
Herr Sebastian Breyer
Handelsregister:
Amtsgericht Dresden, HRB 23835
USt-IdNr.: DE 240935001
Contact
Imprint
AGB
Privacy Statement
Copyright © 2019 • Arevipharma GmbH Generiert: 5 ms